FDA inspection
allphamed PHARBIL Arzneimittel GmbH: FDA inspection ending Nov 19, 2024
FDA inspection 1305638 · Voluntary Action Indicated (VAI) · Gottingen
Key facts
| Inspection ID | 1305638 |
|---|---|
| Firm | allphamed PHARBIL Arzneimittel GmbH |
| FEI number | 3008587095 |
| Address | Hildebrandstr. 10 - 12 |
| City | Gottingen |
| Country | Germany |
| Fiscal year | 2025 |
| Inspection end date | Nov 19, 2024 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data